Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term double-blind comparison of MK-0974 vs rizatriptan for acute migraine
2006-004259-40Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telcagepant in migraine, migraine with aura and migraine without aura (2 arms), sponsored by Merck & Co. Started Mar 2007; status: completed.
02
Drugs
telcagepant
03
Conditions
migrainemigraine with auramigraine without aura
Beyond the preview
Go deeper on 2006-004259-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004259-40.